Tuesday, September 27, 2022 | Back issues
Courthouse News Service Courthouse News Service

$1.7 Billion Merger

Shareholders brought a federal class action against the cancer biotech firm Ignyta for its proposed acquisition by Roche Holding for $27 a share or $1.7 billion.

SAN DIEGO — Shareholders brought a federal class action against the cancer biotech firm Ignyta for its proposed acquisition by Roche Holding for $27 a share or $1.7 billion.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.

Loading
Loading...